Kestra Medical Technologies Ltd.(KMTS)
$28.29+0.02 (+0.07%)
KMTS
Kestra Medical Technologies Ltd. financials statements
$28.29
At close:+0.02 (+0.07%)
Want to see KMTS full AI Analyst Report?
Kestra Medical Technologies Ltd. (KMTS) Ratios
19 Followers
Kestra Medical Technologies Ltd. Ratios
KMTS's free cash flow for Q1 2027 was $-40.63M. For the 2027 fiscal year, KMTS's free cash flow was decreased by $-8.34M and operating cash flow was $-32.30M. See a summary of the company’s cash flow.
| Ratios | Apr 26 | Apr 25 | Apr 24 | Apr 23 | Apr 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 4.41 | 0.45 | 0.50 | 0.50 | 3.96 |
| Quick Ratio | 4.28 | 0.35 | 0.44 | 0.44 | 3.96 |
| Cash Ratio | 1.98 | 0.25 | 0.40 | 0.40 | 3.68 |
| Solvency Ratio | -1.24 | -0.32 | -0.51 | -0.51 | -1.17 |
| Operating Cash Flow Ratio | -1.62 | -2.19 | -1.90 | -1.90 | -4.52 |
| Short-Term Operating Cash Flow Coverage | -2635.58 | 0.00 | -3.41 | -3.41 | 0.00 |
| Net Current Asset Value | $ 123.55M | $ -240.42M | $ -137.81M | $ -137.81M | $ -2.56M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.13 | 0.98 | 1.01 | 1.01 | 0.75 |
| Debt-to-Equity Ratio | 0.18 | -0.22 | -0.33 | -0.33 | 12.94 |
| Debt-to-Capital Ratio | 0.15 | -0.28 | -0.50 | -0.50 | 0.93 |
| Long-Term Debt-to-Capital Ratio | 0.14 | -0.25 | -0.17 | -0.17 | 0.92 |
| Financial Leverage Ratio | 1.38 | -0.22 | -0.33 | -0.33 | 17.28 |
| Debt Service Coverage Ratio | -18.11 | -12.25 | -2.83 | -2.83 | -27.84 |
| Interest Coverage Ratio | -17.85 | -13.65 | -14.29 | -14.29 | -28.00 |
| Debt to Market Cap | 0.04 | 0.04 | 0.03 | 0.03 | 0.02 |
| Interest Debt Per Share | 0.93 | 1.04 | 0.90 | 0.90 | 0.48 |
| Net Debt to EBITDA | 0.39 | -0.48 | -0.33 | -0.33 | 0.05 |
| Profitability Margins | |||||
| Gross Profit Margin | 51.37% | 1.30% | -139.59% | -139.59% | 0.00% |
| EBIT Margin | -153.10% | -315.91% | -1030.07% | -1030.07% | 0.00% |
| EBITDA Margin | -143.94% | -274.34% | -966.44% | -966.44% | 0.00% |
| Operating Profit Margin | -141.64% | -305.83% | -1054.01% | -1054.01% | 0.00% |
| Pretax Profit Margin | -138.04% | -338.30% | -1103.84% | -1103.84% | 0.00% |
| Net Profit Margin | -138.35% | -338.39% | -1104.04% | -1104.04% | 0.00% |
| Continuous Operations Profit Margin | -138.35% | -338.39% | -1104.04% | -1104.04% | 0.00% |
| Net Income Per EBT | 100.22% | 100.03% | 100.02% | 100.02% | 100.55% |
| EBT Per EBIT | 97.46% | 110.62% | 104.73% | 104.73% | 103.69% |
| Return on Assets (ROA) | -36.72% | -204.84% | -217.92% | -217.92% | -111.73% |
| Return on Equity (ROE) | -50.69% | 44.95% | 71.64% | 71.64% | -1930.97% |
| Return on Capital Employed (ROCE) | -43.73% | -655.44% | -4195.15% | -4195.15% | -136.77% |
| Return on Invested Capital (ROIC) | -43.73% | -655.44% | -338.91% | -338.97% | -130.96% |
| Return on Tangible Assets | -36.72% | -204.84% | -217.92% | -217.92% | -111.73% |
| Earnings Yield | -10.88% | -8.70% | -7.79% | -7.79% | -3.15% |
| Efficiency Ratios | |||||
| Receivables Turnover | 6.54 | 13.92 | 3.61 | 3.61 | 0.00 |
| Payables Turnover | 1.69 | 1.15 | 2.97 | 2.97 | 0.00 |
| Inventory Turnover | 6.90 | 8.34 | 8.65 | 8.65 | 0.00 |
| Fixed Asset Turnover | 1.52 | 0.98 | 0.46 | 0.46 | 0.00 |
| Asset Turnover | 0.27 | 0.61 | 0.20 | 0.20 | 0.00 |
| Working Capital Turnover Ratio | 0.49 | -1.53 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -106.64 | -247.70 | 20.24 | 20.24 | 0.00 |
| Days of Sales Outstanding | 55.80 | 26.22 | 101.08 | 101.08 | 0.00 |
| Days of Inventory Outstanding | 52.91 | 43.74 | 42.19 | 42.19 | 0.00 |
| Days of Payables Outstanding | 215.35 | 317.67 | 123.03 | 123.03 | 0.00 |
| Operating Cycle | 108.71 | 69.96 | 143.27 | 143.27 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -1.40 | -1.46 | -1.41 | -1.41 | -0.60 |
| Free Cash Flow Per Share | -2.00 | -1.71 | -1.72 | -1.72 | -0.61 |
| Dividend Paid and CapEx Coverage Ratio | -2.32 | -5.43 | -4.32 | -4.32 | -57.16 |
| Capital Expenditure Coverage Ratio | -2.34 | -5.77 | -4.50 | -4.50 | -88.97 |
| Operating Cash Flow Coverage Ratio | -1.75 | -1.60 | -1.78 | -1.78 | -1.31 |
| Operating Cash Flow to Sales Ratio | -0.86 | -2.60 | -9.13 | -9.13 | 0.00 |
| Free Cash Flow Yield | -9.64% | -7.83% | -7.87% | -7.87% | -2.79% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -8.53 | -11.49 | -12.84 | -12.84 | -31.72 |
| Price-to-Sales (P/S) Ratio | 12.72 | 38.89 | 141.78 | 141.78 | 0.00 |
| Price-to-Book (P/B) Ratio | 4.66 | -5.17 | -9.20 | -9.20 | 612.58 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -10.38 | -12.76 | -12.71 | -12.71 | -35.79 |
| Price-to-Operating Cash Flow Ratio | -14.81 | -14.98 | -15.53 | -15.53 | -36.19 |
| Price-to-Earnings Growth (PEG) Ratio | 0.16 | -0.69 | 0.00 | 0.00 | -1.87 |
| Enterprise Value Multiple | -8.45 | -14.66 | -15.00 | -15.00 | -33.42 |
| Enterprise Value | 1.16B | 1.12B | 1.11B | 1.11B | 1.08B |
| EV to EBITDA | -8.45 | -14.66 | -15.00 | -15.00 | -33.42 |
| EV to Sales | 12.16 | 40.22 | 144.97 | 144.97 | 0.00 |
| EV to Free Cash Flow | -9.92 | -13.20 | -13.00 | -13.00 | -35.74 |
| EV to Operating Cash Flow | -14.16 | -15.49 | -15.88 | -15.88 | -36.14 |
| Tangible Book Value Per Share | 4.45 | -4.23 | -2.37 | -2.37 | 0.04 |
| Shareholders’ Equity Per Share | 4.45 | -4.23 | -2.37 | -2.37 | 0.04 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.00 | -0.00 | -0.00 | -0.00 | -0.01 |
| Revenue Per Share | 1.63 | 0.56 | 0.15 | 0.15 | 0.00 |
| Net Income Per Share | -2.25 | -1.90 | -1.70 | -1.70 | -0.69 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.01 |
| Interest Burden | 0.90 | 1.07 | 1.07 | 1.07 | 1.04 |
| Research & Development to Revenue | 0.20 | 0.56 | 2.07 | 2.07 | 0.00 |
| SG&A to Revenue | 1.73 | 1.05 | 2.50 | 2.50 | 0.00 |
| Stock-Based Compensation to Revenue | 0.35 | 0.05 | 0.16 | 0.16 | 0.00 |
| Income Quality | 0.62 | 0.77 | 0.83 | 0.83 | 0.88 |
Currency in USD

